Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry

NCT06804057 is registered in ClinicalTrials.gov with CorEvitas as lead sponsor.

NCT NCT06804057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06804057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry
Lead sponsor
CorEvitas
Phase
Observational
Overall status
Recruiting
Start date
September 26, 2024
Completion date
December 31, 2099
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus